The Concentration of Pro- and Antiangiogenic Factors in Saliva and Gingival Crevicular Fluid Compared to Plasma in Patients with Peripheral Artery Disease and Type 2 Diabetes

Several studies have investigated various biomarkers in relation to peripheral artery disease (PAD) for disease stratification and early-onset detection. In PAD, angiogenesis is required for tissue restoration and tissue perfusion. Considering changes in angiogenesis in patients with PAD, angiogenic...

Full description

Bibliographic Details
Main Authors: Iwona Gregorczyk-Maga, Aleksandra Szustkiewicz-Karoń, Mateusz Gajda, Maria Kapusta, Wojciech Maga, Martyna Schönborn
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/6/1596
_version_ 1827738495410503680
author Iwona Gregorczyk-Maga
Aleksandra Szustkiewicz-Karoń
Mateusz Gajda
Maria Kapusta
Wojciech Maga
Martyna Schönborn
author_facet Iwona Gregorczyk-Maga
Aleksandra Szustkiewicz-Karoń
Mateusz Gajda
Maria Kapusta
Wojciech Maga
Martyna Schönborn
author_sort Iwona Gregorczyk-Maga
collection DOAJ
description Several studies have investigated various biomarkers in relation to peripheral artery disease (PAD) for disease stratification and early-onset detection. In PAD, angiogenesis is required for tissue restoration and tissue perfusion. Considering changes in angiogenesis in patients with PAD, angiogenic factors could be explored as one of the new prognostic molecules. In recent studies, saliva and gingival crevicular fluid (GCF) have gained recognition as new, easily obtained diagnostic materials. This study aimed to compare the levels of selected circulating angiogenic factors (VEGF-A, PDGF-BB, and ANG-1) in unstimulated whole saliva (WS) and GCF versus plasma at three points in time to find possible correlations between their concentrations among patients with PAD and diabetes type 2 in 32 patients with Rutherford stages 5 and 6. A significant positive correlation has been demonstrated between circulating PDGF-BB levels in GCF and plasma. In most cases, comorbidities do not have an impact on the change in general correlation for the whole group. Our results clearly showed that GCF could be a good source for PDGF assessment. However, future studies with a larger number of subjects are warranted to confirm this finding and identify the most accurate angiogenic biomarkers in saliva or GCF that could be applied in clinical practice.
first_indexed 2024-03-11T02:45:09Z
format Article
id doaj.art-d166c131e8e14c1db658d5ce76e67255
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-11T02:45:09Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-d166c131e8e14c1db658d5ce76e672552023-11-18T09:25:32ZengMDPI AGBiomedicines2227-90592023-05-01116159610.3390/biomedicines11061596The Concentration of Pro- and Antiangiogenic Factors in Saliva and Gingival Crevicular Fluid Compared to Plasma in Patients with Peripheral Artery Disease and Type 2 DiabetesIwona Gregorczyk-Maga0Aleksandra Szustkiewicz-Karoń1Mateusz Gajda2Maria Kapusta3Wojciech Maga4Martyna Schönborn5Faculty of Medicine, Institute of Dentistry, Jagiellonian University Medical College, 31-155 Krakow, PolandFaculty of Medicine, Institute of Dentistry, Jagiellonian University Medical College, 31-155 Krakow, PolandDepartment of Angiology, Faculty of Medicine, Jagiellonian University Medical College, 31-121 Krakow, PolandDepartment of Clinical Biochemistry, Jagiellonian University Medical College, 30-688 Krakow, PolandFaculty of Medicine, Institute of Dentistry, Jagiellonian University Medical College, 31-155 Krakow, PolandDepartment of Angiology, Faculty of Medicine, Jagiellonian University Medical College, 31-121 Krakow, PolandSeveral studies have investigated various biomarkers in relation to peripheral artery disease (PAD) for disease stratification and early-onset detection. In PAD, angiogenesis is required for tissue restoration and tissue perfusion. Considering changes in angiogenesis in patients with PAD, angiogenic factors could be explored as one of the new prognostic molecules. In recent studies, saliva and gingival crevicular fluid (GCF) have gained recognition as new, easily obtained diagnostic materials. This study aimed to compare the levels of selected circulating angiogenic factors (VEGF-A, PDGF-BB, and ANG-1) in unstimulated whole saliva (WS) and GCF versus plasma at three points in time to find possible correlations between their concentrations among patients with PAD and diabetes type 2 in 32 patients with Rutherford stages 5 and 6. A significant positive correlation has been demonstrated between circulating PDGF-BB levels in GCF and plasma. In most cases, comorbidities do not have an impact on the change in general correlation for the whole group. Our results clearly showed that GCF could be a good source for PDGF assessment. However, future studies with a larger number of subjects are warranted to confirm this finding and identify the most accurate angiogenic biomarkers in saliva or GCF that could be applied in clinical practice.https://www.mdpi.com/2227-9059/11/6/1596gingival crevicular fluidangiogenesiscirculating proangiogenic factorcirculating antiangiogenic factorPAD
spellingShingle Iwona Gregorczyk-Maga
Aleksandra Szustkiewicz-Karoń
Mateusz Gajda
Maria Kapusta
Wojciech Maga
Martyna Schönborn
The Concentration of Pro- and Antiangiogenic Factors in Saliva and Gingival Crevicular Fluid Compared to Plasma in Patients with Peripheral Artery Disease and Type 2 Diabetes
Biomedicines
gingival crevicular fluid
angiogenesis
circulating proangiogenic factor
circulating antiangiogenic factor
PAD
title The Concentration of Pro- and Antiangiogenic Factors in Saliva and Gingival Crevicular Fluid Compared to Plasma in Patients with Peripheral Artery Disease and Type 2 Diabetes
title_full The Concentration of Pro- and Antiangiogenic Factors in Saliva and Gingival Crevicular Fluid Compared to Plasma in Patients with Peripheral Artery Disease and Type 2 Diabetes
title_fullStr The Concentration of Pro- and Antiangiogenic Factors in Saliva and Gingival Crevicular Fluid Compared to Plasma in Patients with Peripheral Artery Disease and Type 2 Diabetes
title_full_unstemmed The Concentration of Pro- and Antiangiogenic Factors in Saliva and Gingival Crevicular Fluid Compared to Plasma in Patients with Peripheral Artery Disease and Type 2 Diabetes
title_short The Concentration of Pro- and Antiangiogenic Factors in Saliva and Gingival Crevicular Fluid Compared to Plasma in Patients with Peripheral Artery Disease and Type 2 Diabetes
title_sort concentration of pro and antiangiogenic factors in saliva and gingival crevicular fluid compared to plasma in patients with peripheral artery disease and type 2 diabetes
topic gingival crevicular fluid
angiogenesis
circulating proangiogenic factor
circulating antiangiogenic factor
PAD
url https://www.mdpi.com/2227-9059/11/6/1596
work_keys_str_mv AT iwonagregorczykmaga theconcentrationofproandantiangiogenicfactorsinsalivaandgingivalcrevicularfluidcomparedtoplasmainpatientswithperipheralarterydiseaseandtype2diabetes
AT aleksandraszustkiewiczkaron theconcentrationofproandantiangiogenicfactorsinsalivaandgingivalcrevicularfluidcomparedtoplasmainpatientswithperipheralarterydiseaseandtype2diabetes
AT mateuszgajda theconcentrationofproandantiangiogenicfactorsinsalivaandgingivalcrevicularfluidcomparedtoplasmainpatientswithperipheralarterydiseaseandtype2diabetes
AT mariakapusta theconcentrationofproandantiangiogenicfactorsinsalivaandgingivalcrevicularfluidcomparedtoplasmainpatientswithperipheralarterydiseaseandtype2diabetes
AT wojciechmaga theconcentrationofproandantiangiogenicfactorsinsalivaandgingivalcrevicularfluidcomparedtoplasmainpatientswithperipheralarterydiseaseandtype2diabetes
AT martynaschonborn theconcentrationofproandantiangiogenicfactorsinsalivaandgingivalcrevicularfluidcomparedtoplasmainpatientswithperipheralarterydiseaseandtype2diabetes
AT iwonagregorczykmaga concentrationofproandantiangiogenicfactorsinsalivaandgingivalcrevicularfluidcomparedtoplasmainpatientswithperipheralarterydiseaseandtype2diabetes
AT aleksandraszustkiewiczkaron concentrationofproandantiangiogenicfactorsinsalivaandgingivalcrevicularfluidcomparedtoplasmainpatientswithperipheralarterydiseaseandtype2diabetes
AT mateuszgajda concentrationofproandantiangiogenicfactorsinsalivaandgingivalcrevicularfluidcomparedtoplasmainpatientswithperipheralarterydiseaseandtype2diabetes
AT mariakapusta concentrationofproandantiangiogenicfactorsinsalivaandgingivalcrevicularfluidcomparedtoplasmainpatientswithperipheralarterydiseaseandtype2diabetes
AT wojciechmaga concentrationofproandantiangiogenicfactorsinsalivaandgingivalcrevicularfluidcomparedtoplasmainpatientswithperipheralarterydiseaseandtype2diabetes
AT martynaschonborn concentrationofproandantiangiogenicfactorsinsalivaandgingivalcrevicularfluidcomparedtoplasmainpatientswithperipheralarterydiseaseandtype2diabetes